ID |
SAD
|
BIOLOGIC
|
Sex
|
Age |
Side effects |
Related to the agent |
|---|---|---|---|---|---|---|
3 |
STILL ADULTO |
infliximab |
F |
45 |
Hypersensibility reaction |
Probable |
8 |
PAN |
infliximab |
F |
43 |
Hypersensibility reaction |
Probable |
9 |
VOGT-KOYANAGI |
infliximab |
F |
37 |
Hypersensibility reaction |
Probable |
12 |
SJOGREN |
rituximab |
F |
82 |
Lung neoplasia |
Improbable |
14 |
DERMATOMIOSITIS |
infliximab |
M |
43 |
Hypersensibility reaction |
Probable |
15 |
DERMATOMIOSITIS |
infliximab |
F |
59 |
Herpes infection |
Probable |
16 |
DERMATOMIOSITIS |
etanercept |
F |
75 |
CMV cholecystitis |
Probable |
19 |
WEGENER |
rituximab |
F |
59 |
Trichomonal vaginitis |
Probable |
20 |
LES |
rituximab |
F |
42 |
Colitis |
Little probable |
33 |
WEGENER |
rituximab |
M |
48 |
Sudden death (probable PTE) |
Little probable |
35 |
BEHÇET |
etanercept |
F |
24 |
Probable dysmyelinating disease |
Probable |
37 |
LES |
rituximab |
F |
24 |
Nosocomial pneumonia |
Probable |
43 |
SAF |
rituximab |
F |
51 |
Repeated UTI |
Probable |
45 |
LES |
rituximab |
F |
52 |
Pneumonia |
Probable |
50 |
LES |
rituximab |
F |
31 |
Hypersensibility reaction |
Probable |
51 |
LES |
rituximab |
M |
29 |
Necrotising ascitis |
Improbable |
SIDE EFFECTS: 16/69 (23%)
TYPE OF SIDE EFFECTS OF EACH BIOLOGICAL AGENT